Mga Batayang Estadistika
| CIK | 1113643 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to AXM Pharma, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| October 3, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 12, 2018 Date of Report (Date of earliest event reported) AXM Pharma, Inc. a/k/a Aaron Sparks Industries, Inc. (Exact Name of Registrant as Specified in Charter) FLORIDA 20-0745214 (State or Other Jurisdiction of Incorporat |
|
| October 3, 2018 |
AXM Pharma, Inc./Aaron Sparks Industries, Inc. consolidated financial statements |
|
| October 3, 2018 | ||
| February 25, 2015 |
AXMP / AXM Pharma, Inc. 15-12B - - FORM 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-31886 AXM PHARMA, INC. (Exact name of registrant as specified in its ch |
